Compare CPSS & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CPSS | QSI |
|---|---|---|
| Founded | 1991 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.1M | 165.6M |
| IPO Year | 2010 | 2020 |
| Metric | CPSS | QSI |
|---|---|---|
| Price | $8.81 | $0.77 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 16.3K | ★ 2.7M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1.27 | ★ 28.17 |
| EPS | ★ 0.50 | N/A |
| Revenue | ★ $434,470,000.00 | $2,436,000.00 |
| Revenue This Year | $147.09 | N/A |
| Revenue Next Year | N/A | $618.07 |
| P/E Ratio | $17.82 | ★ N/A |
| Revenue Growth | ★ 10.41 | N/A |
| 52 Week Low | $7.34 | $0.69 |
| 52 Week High | $10.49 | $3.10 |
| Indicator | CPSS | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 39.57 | 45.59 |
| Support Level | $8.89 | $0.70 |
| Resistance Level | $9.69 | $1.04 |
| Average True Range (ATR) | 0.40 | 0.05 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 60.58 | 20.04 |
Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.